FDA ‘rapidly working to finalize’ Pfizer coronavirus vaccine approval
The U.S. Food and Drug Administration (FDA) is working toward quickly finalizing and issuing emergency approval for Pfizer and BioNTech’s coronavirus vaccine candidate, according to top FDA officials.